Ignite Creation Date:
2024-05-06 @ 10:51 AM
Last Modification Date:
2024-10-26 @ 12:36 PM
Study NCT ID:
NCT03367715
Status:
COMPLETED
Last Update Posted:
2022-07-01
First Post:
2017-12-05
Brief Title:
Nivolumab Ipilimumab and Short-course Radiotherapy in Adults With Newly Diagnosed MGMT Unmethylated Glioblastoma
Sponsor:
NYU Langone Health
Organization:
NYU Langone Health
Organization Data
Organization:
NYU Langone Health
Class:
OTHER
Study ID:
17-00218
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
NYU Langone Health
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None